Edgen Stock·Dec 09 2025, 23:37Back
Arcellx Myeloma Data Pressures CAR-T Market
Edgen Stock·Dec 09 2025, 23:37
[1] Kite Announces New Data for Pivotal iMMagine-1 Study at ASH 2025, Highlighting Anito-cel’s Opportunity in Relapsed or Refractory Multiple Myeloma - BioSpace (https://www.biospace.com/press-releases/kite- ...)[2] CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting - BioSpace (https://www.biospace.com/press-releases/carsg ...)[3] CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting – Company Announcement - Financial Times (https://markets.ft.com/data/announce/detail?d ...)
